BlackRock Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 16,203,958 shares of the semiconductor company's stock, valued at approximately $7,228,099,000. BlackRock Inc. owned about 8.46% of Synopsys as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of SNPS. Sankala Group LLC bought a new stake in shares of Synopsys during the fourth quarter worth approximately $25,000. Elevation Wealth Partners LLC lifted its holdings in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys during the 4th quarter worth approximately $28,000. IMG Wealth Management Inc. bought a new stake in Synopsys in the 1st quarter valued at $30,000. Finally, Atlas Capital Advisors Inc. acquired a new position in Synopsys in the 4th quarter valued at $32,000. Institutional investors own 85.47% of the company's stock.
Synopsys Price Performance
Synopsys stock opened at $413.22 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $626.24. The stock has a market capitalization of $79.12 billion, a P/E ratio of 95.65, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. The stock has a fifty day moving average of $424.42 and a 200-day moving average of $442.30.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys's revenue was up 41.9% compared to the same quarter last year. During the same period last year, the firm posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research firms recently commented on SNPS. Piper Sandler raised shares of Synopsys from a "neutral" rating to an "overweight" rating and raised their price target for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Bank of America raised their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a "buy" rating in a report on Thursday, May 28th. Benchmark assumed coverage on Synopsys in a research note on Wednesday, July 15th. They issued a "buy" rating and a $570.00 price target for the company. BNP Paribas Exane increased their price target on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research report on Thursday, May 28th. Finally, Rosenblatt Securities lifted their price objective on Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a report on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $565.06.
Check Out Our Latest Stock Report on SNPS
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
